Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2020 R44 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues Complete
2001 R44 PAR-99-101 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM Complete
2004 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER Complete
2003 R44 PAR-01-104 GOLOVLEV, VAL V SCI-TEC, INC. MAGNETICALLY READABLE MICROARRAY Complete
2009 R44 RFA-CA-07-010 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING Complete
2004 R44 PAR-01-105 BATTRELL, CHARLES FRED MICRONICS, INC. MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER Complete
2003 R44 PAR-01-105 NEDELKOV, DOBRIN INTRINSIC BIOPROBES, INC. AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS Complete
2009 R44 RFA-CA-07-039 GUO, BAOCHUAN GLC BIOTECHNOLOGY, INC. MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY Complete
2007 R44 RFA-CA-07-008 DOLINGER, DAVID LEE IQUUM, INC. RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS Complete
2014 R44 PAR-13-327 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2003 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. ARTIFICIAL ANTIBODY MIMETICS Complete
2009 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2007 R44 RFA-CA-07-010 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING Complete
2010 R44 RFA-CA-08-011 DUFFY, DAVID C TWIN LIGHTS BIOSCIENCE, INC. SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS Complete
2003 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER Complete
2009 R44 RFA-CA-06-006 SCHWARZBACH, ANNA ASURAGEN, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2010 R44 RFA-CA-08-011 CHEN, WEN-TIEN VITATEX, INC. CANCER PROGENIYOR CELL MARKERS Complete
2017 R44 PAR-13-327 PREMSRIRUT, PREM KHOVABUTR MIRIMUS, INC. Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research Complete
2003 R44 PAR-01-105 WIKTOR, PETER J. ENGINEERING ARTS PIEZOELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS Complete
2002 R44 PAR-99-101 GAO, JUN CALIBRANT BIOSYSTEMS, INC. ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS Complete
2019 R43 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 PAR-98-066 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2000 R43 PAR-99-101 CHO, RAYMOND JAIHYUN INGENUITY SYSTEMS, INC. FUNCTIONAL CLUSTERING APPROACH TO GENOMIC ANALYSIS Complete
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations Complete
1999 R43 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. PARALLEL ARRAY PROCESSOR Complete
2005 R43 RFA-CA-05-006 KIM, RAYMOND GENEPRISM, INC. MULTIPLEXED PROTEIN BIOCHIP ASSAYS--SIGNAL AMPLIFICATION Complete
2019 R43 PAR-18-303 KASOJI, SANDEEP TRIANGLE BIOTECHNOLOGY, INC. SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples Complete
1999 R43 PAR-98-066 BEACH, DAVID H. GENETICA, INC. TECHNOLOGIES FOR GENETIC MANIPULATION OF TUMOR CELLS Complete
2005 R43 RFA-CA-05-006 LU, CHIUNG-MEI GENACO BIOMEDICAL PRODUCTS, INC. EXPRESSION PROFILING OF MICRORNAS WITH BEAD ARRAY Complete
2019 R43 PAR-18-303 BROWN, MARK T CLAREMONT BIOSOLUTIONS, LLC Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis Complete
1999 R43 PAR-98-066 WINZER-SERHAN, URSULA H AMBION, INC. DEVELOPMENT OF RNA FRIENDLY, HISTOLOGICAL FIXATIVES Complete
2005 R43 RFA-CA-05-006 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DETECTING INTEGRATED HPV DNA IN IMMUNOCOMPROMISED WOMEN Complete
2008 R43 RFA-CA-07-039 TYRRELL, STEVEN PATRICK CONTROLLED PROCESS TECHNOLOGIES, LLC A RAPID SOLUTION-PHASE IMMUNOASSAY FOR PROTEOMICS Complete
2005 R43 RFA-CA-05-006 LIM, MARK AMBERGEN, INC ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE Complete
2008 R43 RFA-CA-07-043 PAMULA, VAMSEE K ADVANCED LIQUID LOGIC MULTIPLEXING CANCER SAMPLE PREPARATION: INDIRECT IMMUNOMAGNETIC ENRICHMENT Complete
2005 R43 RFA-CA-05-007 PHILIP, RAMILA IMMUNOTOPE, INC. IDENTIFICATION OF AUTO ANTIGENS IN OVARIAN CANCER Complete
2008 R43 RFA-CA-07-041 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC QUANTITATIVE PROTEOMICS OF METASTASIS Complete
2021 R43 PAR-18-303 ALLEN, JEFFREY KEITH TUMORGEN, INC. Capture and Characterization of Highly Metastatic Cancer Cell Clusters in Transit from Lung Cancer Patient Whole Blood Specimens. Active
2008 R43 RFA-CA-07-041 CHAN, DOUG PROTECH LABORATORIES, INC. DEVELOPMENT AND APPLICATION OF TECHNOLOGY PLATFORM FOR IDENTIFICATION OF THE HIST Complete
2015 R43 PAR-13-327 SELIGMANN, BRUCE E. BIOSPYDER TECHNOLOGIES, INC. IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE Complete
2008 R43 RFA-CA-07-041 CHENCHIK, ALEX CELLECTA, INC. ARRAY-ASSISTED INSERTIONAL MUTAGENESIS PLATFORM FOR FORWARD GENETICS OF CANCER Complete
2015 R43 PAR-13-327 LELENTAL, MARK CATASSAYS NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION Complete
2006 R43 RFA-CA-06-006 BEAUDENON, SYLVIE LUCIE AMBION DIAGNOSTICS, INC. ONCOGENIC MICRORNAS IN HPV-INFECTED CERVICAL SAMPLES Complete
2008 R43 RFA-CA-07-039 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. ABSCRIPTION?-BASED CPG METHYLATION ASSAYS FOR EARLY CANCER DETECTION Complete
2011 R43 RFA-CA-10-013 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2015 R43 PAR-13-327 MANDECKI, WLODEK PHARMASEQ, INC. SEQUENECE-SPECIFIC DETECTION OF PROTEASES USING ELECTRONIC P-CHIPS IN MULTIPLEX FORMAT Complete
2006 R43 RFA-CA-06-005 MOON, JOHN A ILLUMINA, INC. MICROFLUIDIC CAPILLARY ASSAY UTILIZING HOLOGRAPHICALLY * Complete
2008 R43 RFA-CA-07-041 MATHEW, ANU MESO SCALE DIAGNOSTICS, LLC MULTIPLEXED BIOMARKER PANELS FOR EARLY DETECTION OF PROSTATE CANCER Complete
2011 R43 RFA-CA-10-013 RUAN, BIAO POTOMAC AFFINITY PROTEINS, LLC PROTEASE CHAIN REACTIONS FOR MOLECULAR ANALYSIS OF CANCER MARKERS Complete
2015 R43 PAR-13-327 JIANG, LI A'AS, INC. KS-DETECT: A SOLAR-POWERED AND SMARTPHONE INTEGRATED INSTRUMENT FOR POINT-OF-CARE DIAGNOSIS OF KAPOSI'S SARCOMA Complete

Pages